Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

The Saturday Edition | 23 May 2026
32:37

Afternoon Report | GYG comes home
03:52

Hopes rate hikes on pause; could house prices fall 10pc; SpaceX $US2 trillion IPO
17:57